AAAAAA
Results:
1-16
|
Results: 16
Authors:
LANGFORD CA
Citation: Ca. Langford, THE DIAGNOSTIC UTILITY OF C-ANCA IN WEGENERS-GRANULOMATOSIS, Cleveland Clinic journal of medicine, 65(3), 1998, pp. 135-140
Authors:
SUMMERS RM
SELBIE WS
MALLEY JD
PUSANIK LM
DWYER AJ
COURCOUTSAKIS NA
SHAW DJ
KLEINER DE
SNELLER MC
LANGFORD CA
HOLLAND SM
SHELHAMER JH
Citation: Rm. Summers et al., POLYPOID LESIONS OF AIRWAYS - EARLY EXPERIENCE WITH COMPUTER-ASSISTEDDETECTION BY USING VIRTUAL BRONCHOSCOPY AND SURFACE CURVATURE, Radiology, 208(2), 1998, pp. 331-337
Authors:
LUDVIKSSON BR
SNELLER MC
CHUA KS
TALARWILLIAMS C
LANGFORD CA
EHRHARDT RO
FAUCI AS
STROBER W
Citation: Br. Ludviksson et al., ACTIVE WEGENERS GRANULOMATOSIS IS ASSOCIATED WITH HLA-DR-CELLS EXHIBITING AN UNBALANCED TH1-TYPE T-CELL CYTOKINE PATTERN - REVERSAL WITH IL-10( CD4(+) T), The Journal of immunology, 160(7), 1998, pp. 3602-3609
Authors:
LANGFORD CA
SNELLER MC
Citation: Ca. Langford et Mc. Sneller, PULSE VERSUS ORAL CYCLOPHOSPHAMIDE IN THE TREATMENT OF WEGENERS GRANULOMATOSIS - COMMENT ON THE ARTICLE BY GUILLEVIN ET-AL, Arthritis and rheumatism, 41(9), 1998, pp. 1706-1707
Authors:
LANGFORD CA
KLIPPEL JH
BALOW JE
JAMES SP
SNELLER MC
Citation: Ca. Langford et al., USE OF CYTOTOXIC AGENTS AND CYCLOSPORINE IN THE TREATMENT OF AUTOIMMUNE-DISEASE - PART 2 - INFLAMMATORY BOWEL-DISEASE, SYSTEMIC VASCULITIS,AND THERAPEUTIC TOXICITY, Annals of internal medicine, 129(1), 1998, pp. 49-58
Authors:
LANGFORD CA
KLIPPEL JH
BALOW JE
JAMES SP
SNELLER MC
Citation: Ca. Langford et al., USE OF CYTOTOXIC AGENTS AND CYCLOSPORINE IN THE TREATMENT OF AUTOIMMUNE-DISEASE PART-1 - RHEUMATOLOGIC AND RENAL DISEASES, Annals of internal medicine, 128(12), 1998, pp. 1021-1028
Authors:
LANGFORD CA
Citation: Ca. Langford, COMPLICATIONS OF CYCLOPHOSPHAMIDE THERAPY, European archives of oto-rhino-laryngology, 254(2), 1997, pp. 65-72
Authors:
LANGFORD CA
SNELLER MC
HOFFMAN GS
Citation: Ca. Langford et al., METHOTREXATE USE IN SYSTEMIC VASCULITIS, Rheumatic diseases clinics of North America, 23(4), 1997, pp. 841
Authors:
LANGFORD CA
VANWAES C
Citation: Ca. Langford et C. Vanwaes, UPPER AIRWAY-OBSTRUCTION IN THE RHEUMATIC DISEASES, Rheumatic diseases clinics of North America, 23(2), 1997, pp. 345
Authors:
COURCOUTSAKIS NA
LANGFORD CA
SNELLER MC
CUPPS TR
GORMAN K
PATRONAS NJ
Citation: Na. Courcoutsakis et al., ORBITAL INVOLVEMENT IN WEGENER GRANULOMATOSIS - MR FINDINGS IN 12 PATIENTS, Journal of computer assisted tomography, 21(3), 1997, pp. 452-458
Authors:
FOWLER WC
KIM J
COX T
LANGFORD CA
STCLAIR EW
Citation: Wc. Fowler et al., OCULAR SURFACE STAINING CHARACTERISTICS OF LISSAMINE GREEN AND ROSE-BENGAL IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA AND PRIMARY SJOGRENS-SYNDROME, Investigative ophthalmology & visual science, 38(4), 1997, pp. 741-741
Authors:
LANGFORD CA
SNELLER MC
Citation: Ca. Langford et Mc. Sneller, FINDING A VALID MODEL FOR ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATEDVASCULITIS - REPLY, Arthritis and rheumatism, 40(5), 1997, pp. 987-987
Authors:
LANGFORD CA
FAUCI AS
TALARWILLIAMS C
SNELLER MC
Citation: Ca. Langford et al., TREATMENT OF WEGENERS-GRANULOMATOSIS WITH METHOTREXATE AND GLUCOCORTICOIDS - UPDATE ON RATE OF RELAPSE, Arthritis and rheumatism, 39(9), 1996, pp. 1102-1102
Authors:
LANGFORD CA
SNELLER MC
Citation: Ca. Langford et Mc. Sneller, FINDING A VALID MODEL FOR HUMAN WEGENERS GRANULOMATOSIS - COMMENT, Arthritis and rheumatism, 39(7), 1996, pp. 1262-1262
Authors:
LANGFORD CA
SNELLER MC
HALLAHAN CW
HOFFMAN GS
KAMMERER WA
TALARWILLIAMS C
FAUCI AS
LEBOVICS RS
Citation: Ca. Langford et al., CLINICAL-FEATURES AND THERAPEUTIC MANAGEMENT OF SUBGLOTTIC STENOSIS IN PATIENTS WITH WEGENERS GRANULOMATOSIS, Arthritis and rheumatism, 39(10), 1996, pp. 1754-1760
Authors:
LANGFORD CA
SNELLER MC
HALLAHAN CW
HOFFMAN GS
KAMMERER WA
TALARWILLIAMS C
FAUCI AS
LEBOVICS RS
Citation: Ca. Langford et al., CLINICAL-FEATURES AND THERAPEUTIC MANAGEMENT OF SUBGLOTTIC STENOSIS IN PATIENTS WITH WEGENERS GRANULOMATOSIS, Arthritis and rheumatism, 38(9), 1995, pp. 1424-1424
Risultati:
1-16
|